BRC News

Men are almost three times as likely as women to be admitted to intensive care and have 40% higher odds of dying from Covid-19, according to a new study led by researchers at UCL, Great Ormond Street Hospital and the University of Cape Town.

Cutting-edge research aimed at increasing adult hearing aid use could make a dramatic change to people with hearing loss.  

New guidance on public involvement in lab-based research has been published by the UCLH BRC, Alzheimer’s Society and Parkinson’s UK, in partnership with patients and researchers.

Cancer and cancer treatment are both independent risk factors for mortality following Covid-19 infection, according to UCLH led research which highlights the ongoing need to protect cancer patients during the pandemic.

The Nursing Team at the NIHR UCLH Clinical Research Facility (CRF) have won the Contribution to World Class Research Award at the 2020 UCLH Celebrating Excellence Awards.

The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its ‘Phase 3’ trials which involved UCLH that show its candidate vaccine is effective at preventing COVID-19 and offers a high level of protection.

The team at UCLH, UCL and Mercedes HPP that developed a life-saving breathing device at the height of the pandemic has been shortlisted for the 2020 HSJ Award for Acute Innovation of the Year.

More ‘Generation Z’ boys and girls in the UK are dieting to lose weight than in previous generations, and are likely to overestimate their own weight, finds a new UCL-led study.

A three year plan to improve the health and lives of people living with obesity has been launched by the Obesity Empowerment Network (OEN UK), which was co-founded by the BRC’s Obesity theme lead Professor Rachel Batterham.

A simple new blood test that could speed up drug discovery for the treatment of a type of inherited ataxia has been developed by researchers from the Ataxia Centre at UCL Queen Square Institute of Neurology and from Mayo Clinic in Florida.

More than two-thirds of patients hospitalised due to COVID-19 continue to suffer from debilitating symptoms more than seven weeks after being discharged, according to a new study carried out at University College London Hospitals NHS Trust (UCLH), Barnet Hospital, and the Royal Free Hospital.

The BRC has published a magazine for patients and the public on the latest COVID-19 research at UCLH. 

UCLH is the first hospital in the world to treat a Covid-19 patient with nebulised (inhaled) surfactant – a substance which makes it easier to breathe – as part of a clinical trial. Lung surfactant is a substance that reduces the work of breathing and prevents the lungs from collapsing. In some

People with COVID-19 who experience a stroke appear to be left with greater disability after the stroke, according a study led by UCL and UCLH researchers.

Professor Sir Alimuddin (Ali) Zumla has led efforts to tackle Covid-19 internationally from the very start of the pandemic. Read our profile of Sir Ali and his work.